33374784|t|Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson's Disease.
33374784|a|Dysbiosis is implicated by many studies in the pathogenesis of Parkinson's disease (PD). Advances in sequencing technology and computing have resulted in confounding data regarding pathogenic bacterial profiles in conditions such as PD. Changes in the microbiome with reductions in short-chain fatty acid (SCFA)-producing bacteria and increases in endotoxin-producing bacteria likely contribute to the pathogenesis of PD. GPR109A, a G-protein coupled receptor found on the surface of the intestinal epithelium and immune cells, plays a key role in controlling intestinal permeability and the inflammatory cascade. The absence of GPR109A receptors is associated with decreased concentration of tight junction proteins, leading to increased intestinal permeability and susceptibility to inflammation. In inflammatory states, butyrate acts via GPR109A to increase concentrations of tight junction proteins and improve intestinal permeability. Niacin deficiency is exacerbated in PD by dopaminergic medications. Niacin supplementation has been shown to shift macrophage polarization from pro-inflammatory to an anti-inflammatory profile. Niacin and butyrate, promising nutrients and unique ligands for the G protein-coupled receptor GPR109A, are reviewed in this paper in detail.
33374784	0	6	Niacin	Chemical	MESH:D009525
33374784	11	19	Butyrate	Chemical	MESH:D002087
33374784	46	55	Dysbiosis	Disease	MESH:D064806
33374784	87	106	Parkinson's Disease	Disease	MESH:D010300
33374784	108	117	Dysbiosis	Disease	MESH:D064806
33374784	171	190	Parkinson's disease	Disease	MESH:D010300
33374784	192	194	PD	Disease	MESH:D010300
33374784	341	343	PD	Disease	MESH:D010300
33374784	390	412	short-chain fatty acid	Chemical	MESH:D005232
33374784	414	418	SCFA	Chemical	MESH:D005232
33374784	430	438	bacteria	Species	629395
33374784	476	484	bacteria	Species	629395
33374784	526	528	PD	Disease	MESH:D010300
33374784	530	537	GPR109A	Gene	338442
33374784	541	567	G-protein coupled receptor	Gene	10663
33374784	700	712	inflammatory	Disease	MESH:D007249
33374784	893	905	inflammation	Disease	MESH:D007249
33374784	910	922	inflammatory	Disease	MESH:D007249
33374784	931	939	butyrate	Chemical	MESH:D002087
33374784	949	956	GPR109A	Gene	338442
33374784	1048	1065	Niacin deficiency	Disease	MESH:D007153
33374784	1084	1086	PD	Disease	MESH:D010300
33374784	1090	1114	dopaminergic medications	Chemical	-
33374784	1116	1122	Niacin	Chemical	MESH:D009525
33374784	1196	1208	inflammatory	Disease	MESH:D007249
33374784	1220	1232	inflammatory	Disease	MESH:D007249
33374784	1242	1248	Niacin	Chemical	MESH:D009525
33374784	1253	1261	butyrate	Chemical	MESH:D002087
33374784	1310	1336	G protein-coupled receptor	Gene	10663
33374784	1337	1344	GPR109A	Gene	338442
33374784	Association	MESH:D007249	10663
33374784	Association	MESH:D009525	10663
33374784	Association	MESH:D002087	338442
33374784	Negative_Correlation	MESH:D005232	MESH:D010300
33374784	Negative_Correlation	MESH:D009525	MESH:D064806
33374784	Association	MESH:D007249	338442
33374784	Association	MESH:D009525	338442
33374784	Association	MESH:D002087	10663
33374784	Negative_Correlation	MESH:D002087	MESH:D064806
33374784	Negative_Correlation	MESH:D009525	MESH:D007249

